NASDAQ:MBIO - Mustang Bio, Inc.
$3.36
 $-0.04
-1.18%
4:00PM EDT
2019-07-15
Mustang Bio, Inc., incorporated on March 13, 2015, is a clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of cancer immunotherapy products designed to utilize the power of the patients own immune system to eliminate cancer cells. It seeks to acquire rights to technologies by licensing or otherwise acquiring an ownership interest in the technologies, funding their research and development and eventually either out-licensing or bringing the technologies to market.The Company is developing its proprietary Chimeric Antigen Receptor (CAR) engineered T cells (CAR -T) technology, which uses the patients own T cells to engage and destroy specific tumors. The Company, through its agreement with City of Hope National Medical Center, is using three novel CAR T therapies in the development of cancer treatments. The CAR T therapies covered under the agreements include human epidermal growth factor receptor 2 (HER2) CAR T technology (HER2 Technology), which is initially applied in the treatment of glioblastoma multiforme; CS1-specific CAR T technology (CS1 Technology), which is to be directed against multiple myeloma; and prostate stem cell antigen (PSCA) CAR T technology (PSCA Technology), which is to be used in the treatment of prostate cancer.. Read more at  reuters.com
sector:  health care
industry:  biotechnology
the data below are updated and published after 9pm EDT each trading day
  MBIO     avg for
industry  
  avg for
sector  
42 stocks weight:  8. 14   114. 77   204. 78  
42 stocks rank:  4. 00 K 1. 44 K 810. 33  
# analyst opinions:  3. 00   13. 59   13. 86  
mean recommendation:  1. 30   2. 12   2. 04  

quick ratio:  5. 53   5. 48   1. 89  
current ratio:  5. 64   5. 85   2. 40  

target price low:  2. 10   82. 72   115. 11  
target price avg:  4. 88   104. 42   138. 02  
target price high:  7. 00   130. 64   159. 47  
1-yr high:  7. 47   110. 27   142. 72  
last close:  3. 40   85. 12   126. 54  
50-day avg:  3. 66   86. 06   122. 35  
200-day avg:  3. 90   88. 76   121. 75  
1-yr low:  2. 30   69. 26   100. 63  
volume:  131. 66 K 3. 51 M 5. 53 M
50-day avg volume:  361. 84 K 3. 21 M 4. 22 M
200-day avg volume:  415. 81 K 3. 04 M 4. 75 M

1-day return:  -0. 87 % -0. 30 % -1. 01 %
this week return:  -2. 86 % -2. 16 % -1. 35 %
12-wk return:  -39. 72 % 3. 34 % 8. 69 %
52-wk return:  -52. 69 % -1. 76 % 12. 22 %

enterprise value (EV):  114. 03 M 46. 50 B 123. 99 B
market cap:  136. 89 M 40. 77 B 109. 11 B
EBITDA:  -33. 64 M 4. 33 B 8. 19 B
enterprise multiple (EV/EBITDA):  -3. 39   5. 45   12. 05  
total debt:  14. 73 M 11. 27 B 17. 58 B
debt/equity:  51. 73   57. 36   120. 25  
net income (common):  -33. 99 M 2. 13 B 4. 27 B

shares outstanding:  26. 61 M 551. 08 M 1. 24 B
shares:  27. 44 M 559. 41 M 1. 22 B
shares short:  585. 12 K 11. 15 M 11. 94 M
shares short prior month:  679. 87 K 9. 31 M 11. 96 M
short ratio:  1. 85   5. 72   3. 43  
short % of float:  3. 02 % 6. 40 % 2. 65 %
total cash/share:  1. 02   11. 00   9. 23  
total cash:  40. 64 M 6. 03 B 6. 01 B
free cash flow:  -23. 11 M 3. 02 B 4. 96 B
operating cash flow:  -20. 16 M 3. 92 B 5. 99 B

book value:  1. 01   13. 02   27. 49  
price/book:  3. 35   4. 21   8. 80  
operating margins:  0. 00 % -380. 20 % -38. 44 %
EBITDA margins:  0. 00 % 13. 59 % 23. 24 %
profit margins:  0. 00 % 10. 94 % 14. 00 %
gross margins:  0. 00 % 36. 11 % 55. 16 %

1-yr max volatility:  112. 24 % --- ---
1-yr mean volatility:  4. 45 % 1. 50 % 1. 08 %

1-yr EPS:  -1. 24   2. 12   4. 26  
forward EPS:  -1. 06   3. 47   7. 14  
P/E:  -2. 74   2. 15   33. 17  
forward P/E:  -3. 24   -4. 03   17. 60  
PE/G:  0. 14   0. 54   0. 34  
growth:  -19. 94 % 263. 03 % 78. 34 %
earnings high:  -0. 24   0. 91   1. 70  
earnings avg:  -0. 25   0. 71   1. 58  
earnings low:  -0. 26   0. 48   1. 46  
revenue high:  -0. 00   2. 64 B 11. 26 B
revenue avg:  -0. 00   2. 58 B 11. 09 B
revenue low:  -0. 00   2. 54 B 10. 90 B
return on assets:  -38. 71 % -2. 31 % 5. 31 %
return on equity:  -80. 82 % -82. 48 % 135. 30 %

beta (1yr vs S&P500):  0. 93   1. 26   0. 91  
sharpe (1yr):  -0. 03   0. 07   0. 77  

held % insiders:  39. 58 % 6. 08 % 3. 31 %
held % institutions:  9. 14 % 78. 36 % 69. 61 %

Research more with google or yahoo!
the data below are updated and re-published at 8pm EDT after each trading day

2019-07-14 : MBIO
.    101.476 =       101.476 :: --> INITIAL WEIGHT <--
.    - 1.243 =       100.233 :: earnings per-share addition
.                               --> FUNDAMENTALS <--
.     x 2.02 =       202.473 :: P/E factor
.    x 1.643 =       332.711 :: PE/G factor
.    x 1.527 =       507.991 :: beta factor
.    x 0.648 =       329.187 :: sharpe factor
.    x 2.964 =       975.765 :: current ratio factor
.    x 1.105 =      1078.143 :: quick ratio factor
.    x 1.241 =      1338.175 :: short ratio factor
.    x 1.038 =      1389.067 :: price-to-book factor
.    x 1.379 =       1915.69 :: debt-to-equity factor
.                               --> PERFORMANCE <--
.    x 2.114 =       4049.74 :: sector+industry 1-year gains factor
.    x 1.033 =      4184.993 :: industry 12-weeks return factor
.    x 1.305 =      5462.561 :: industry 2-weeks return factor
.     / 2.18 =      2506.286 :: overall "drift" factor
.    x 0.625 =      1566.063 :: largest single-day jump factor
.    x 0.073 =       113.648 :: low price factor
.    x 0.471 =        53.487 :: notable returns + performance factor
.                               --> PROJECTIONS <--
.    x 0.982 =        52.504 :: forward EPS factor
.    x 0.993 =        52.154 :: forward P/E factor
.    x 1.182 =        61.669 :: industry recommendation factor
.    x 2.697 =       166.317 :: company recommendation factor
.    x 1.008 =       167.589 :: factor historical industry gain for week 28
.    x 0.906 =       151.773 :: target low factor
.     x 1.22 =       185.148 :: target mean factor
.    x 1.043 =        193.15 :: target high factor
.    x 10.65 =      2057.103 :: spline projection factor
.                               --> FINAL ADJUSTMENTS <--
.  quad root =         6.735 :: reduced for readability
.    + 1.404 =         8.139 :: add/subtract for investor sentiment
.                               --> FINAL WEIGHT <--
.                      8.139 :: FINAL WEIGHT for NASDAQ:MBIO


 


News feed RSS items generated from finance.google.com

News feed formatting by feed2js.org